Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 22 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
10(76.9%)
Phase 4
2(15.4%)
Phase 3
1(7.7%)
13Total
N/A(10)
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT07496710Completed

Relationship Between Nutritional Status, Physical Activity and Periodontal Status

Role: collaborator

NCT07477821Recruiting

A Muscle-brain Interplay Study in Neurological Disorders

Role: collaborator

NCT04102774Not ApplicableCompleted

Effect of AIRVO Heated Humidification in Bronchiectasis

Role: collaborator

NCT06193577Not ApplicableRecruiting

Effect of Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters

Role: collaborator

NCT05940311Recruiting

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

Role: collaborator

NCT05817292Completed

Study of the Vaginal Microbiota in Women Under Fertile Age

Role: lead

NCT05784376Unknown

The Southern Italian Children, Adolescents and PaRents COhort Study on Nutrition and Health

Role: collaborator

NCT04300868Unknown

Immunisation Status and Safety of Vaccines in Italian MS Patients

Role: collaborator

NCT02124187Not ApplicableUnknown

Smoking Cessation And Reduction in Depression

Role: lead

NCT01979796Not ApplicableUnknown

Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.

Role: lead

NCT02124226Phase 3Unknown

Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma

Role: lead

NCT01387425Not ApplicableCompleted

Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE)

Role: lead

NCT02398487Not ApplicableCompleted

Personal Vaporizer vs Cigalike

Role: lead

NCT02124200Phase 4Completed

High Cessation Rates in Smokers Using Personal Vaporizers

Role: lead

NCT01195597Not ApplicableCompleted

Smoking Cessation and Reduction With an Electronic Nicotine Delivery Device (ENDD)

Role: lead

NCT01164072Completed

Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette)

Role: lead

NCT01188239Completed

A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette)

Role: lead

NCT01194583Completed

Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges

Role: lead

NCT01735487Not ApplicableCompleted

CogEcig: Cognitive Functioning and Electronic Cigarette

Role: lead

NCT01665066Not ApplicableCompleted

Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes

Role: lead